Echo IQ seen facing selloff after FDA clearance denial
Petra Capital says Echo IQ shares are likely to be sold today after the U.S. FDA didn’t clear its EchoSolv HF heart-failure detection tool. The regulator issued a Not Substantially Equivalent determination.